Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Lancet. Infectious Diseases (Print)

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/S1473-3099(16)30323-1PMID 27979695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influenza

  2017cited by this paper
• Spiromastilactones: A new class of influenza virus inhibitors from deep-sea fungus.

  2016cited by this paper
• Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites

  2016cited by this paper
• Bastimolide A, a Potent Antimalarial Polyhydroxy Macrolide from the Marine Cyanobacterium Okeania hirsuta.

  2015cited by this paper
• Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections

  2015cited by this paper
• Elicitation of secondary metabolism in actinomycetes.

  2015cited by this paper
• Malaria medicines: a glass half full?

  2015cited by this paper
• Salinipostins A-K, long-chain bicyclic phosphotriesters as a potent and selective antimalarial chemotype.

  2015cited by this paper
• Marine Peptides and Their Anti-Infective Activities

  2015cited by this paper
• The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations

  2015cited by this paper
• Integration of high-content screening and untargeted metabolomics for comprehensive functional annotation of natural product libraries

  2015cited by this paper
• Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.

  2015cited by this paper
• Antimicrobial resistance: what's needed.

  2015cited by this paper
• Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health.

  2015cited by this paper
• The re-emergence of natural products for drug discovery in the genomics era

  2015cited by this paper
• Anti-parasite drugs sweep Nobel prize in medicine 2015

  2015cited by this paper
• Malaria: Fifteen years of interventions

  2015cited by this paper
• Illuminating the dark matter in metabolomics

  2015cited by this paper
• Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans

  2015cited by this paper
• A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria

  2015cited by this paper
• Antibiotics, copayments, and antimicrobial resistance: investment matters.

  2015cited by this paper
• New horizons for old drugs and drug leads.

  2014cited by this paper
• Diversity, abundance and natural products of marine sponge-associated actinomycetes.

  2014cited by this paper
• Resistance-resistant antibiotics.

  2014cited by this paper
• Microbiology: Barriers to the spread of resistance

  2014cited by this paper
• Marine natural products.

  2014cited by this paper
• Induction of Candida albicans Drug Resistance Genes by Hybrid Zinc Cluster Transcription Factors

  2014cited by this paper
• Antibiotic resistance needs global solutions.

  2014cited by this paper
• Strategies to combat antimicrobial resistance.

  2014cited by this paper
• Role of Different Pfcrt and Pfmdr-1 Mutations in Conferring Resistance to Antimalaria Drugs in Plasmodium falciparum

  2014cited by this paper
• Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success

  2014cited by this paper
• Forazoline A: marine-derived polyketide with antifungal in vivo efficacy.

  2014cited by this paper
• Pharmaceutically active secondary metabolites of marine actinobacteria.

  2014cited by this paper
• Combination approaches to combat multidrug-resistant bacteria.

  2013cited by this paper
• Thiaplakortones A-D: antimalarial thiazine alkaloids from the Australian marine sponge Plakortis lita.

  2013cited by this paper
• A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

  2013cited by this paper
• Metagenomic approaches for exploiting uncultivated bacteria as a resource for novel biosynthetic enzymology.

  2013cited by this paper
• Marine bacteria: potential sources for compounds to overcome antibiotic resistance

  2013cited by this paper
• Polypharmacology - foe or friend?

  2013cited by this paper
• Discovery and preliminary structure-activity relationship analysis of 1,14-sperminediphenylacetamides as potent and selective antimalarial lead compounds.

  2013cited by this paper
• Herpes simplex virus drug-resistance: new mutations and insights.

  2013cited by this paper
• Influenza virus resistance to neuraminidase inhibitors.

  2013cited by this paper
• HIV-1 reverse transcriptase and antiviral drug resistance. Part 1.

  2013cited by this paper
• Asperterrestide A, a cytotoxic cyclic tetrapeptide from the marine-derived fungus Aspergillus terreus SCSGAF0162.

  2013cited by this paper
• Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73.

  2013cited by this paper
• Artemisinin resistance or artemisinin-based combination therapy resistance?

  2013cited by this paper
• HIV-1 reverse transcriptase and antiviral drug resistance. Part 2.

  2013cited by this paper
• Marine natural products with anti-HIV activities in the last decade.

  2013cited by this paper
• Antiviral agents for herpes simplex virus.

  2013cited by this paper
• The Bis(Indolyl)Imidazole Alkaloid Nortopsentin A Exhibits Antiplasmodial Activity

  2013cited by this paper
• Renaissance of Marine Natural Product Drug Discovery and Development

  2012cited by this paper
• Lessons from the past and charting the future of marine natural products drug discovery and chemical biology.

  2012cited by this paper
• High content live cell imaging for the discovery of new antimalarial marine natural products

  2012cited by this paper
• Candida Infections and Their Prevention

  2012cited by this paper
• Aurantoside K, a New Antifungal Tetramic Acid Glycoside from a Fijian Marine Sponge of the Genus Melophlus

  2012cited by this paper
• Marine natural products.

  2012cited by this paper
• Systematic Identification of Synergistic Drug Pairs Targeting HIV

  2012cited by this paper
• Vaccines and antibiotic resistance.

  2012cited by this paper
• The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans

  2012cited by this paper
• Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp.

  2012cited by this paper
• Pentacyclic Ingamine Alkaloids, a New Antiplasmodial Pharmacophore from the Marine Sponge Petrosid Ng5 Sp5

  2012cited by this paper
• Vaccines for the twenty-first century society

  2011cited by this paper
• The in vivo anti-plasmodial activity of haliclonacyclamine A, an alkaloid from the marine sponge, Haliclona sp.

  2011cited by this paper
• Accessing the Hidden Majority of Marine Natural Products through Metagenomics

  2011cited by this paper
• Natural products as starting points for future anti-malarial therapies: going back to our roots?

  2011cited by this paper
• Marine natural products: a new wave of drugs?

  2011cited by this paper
• Challenges in antimalarial drug discovery.

  2011cited by this paper
• Marine organisms as a therapeutic source against herpes simplex virus infection.

  2011cited by this paper
• Regulation of multidrug resistance in pathogenic fungi.

  2010cited by this paper
• Antiviral Lead Compounds from Marine Sponges

  2010cited by this paper
• Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders

  2010cited by this paper
• The odyssey of marine pharmaceuticals: a current pipeline perspective.

  2010cited by this paper
• Transporters as mediators of drug resistance in Plasmodium falciparum.

  2010cited by this paper
• Novel Anti-Infective Compounds from Marine Bacteria

  2010cited by this paper
• Metagenomic approaches to natural products from free-living and symbiotic organisms.

  2009cited by this paper
• Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp.

  2009cited by this paper
• Secondary metabolomics: natural products mass spectrometry goes global.

  2009cited by this paper
• Update: influenza activity - United States, September 28, 2008--January 31, 2009.

  2009cited by this paper
• Drug development from marine natural products

  2009cited by this paper
• Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

  2009cited by this paper
• Benefits of using multiple first-line therapies against malaria

  2008cited by this paper
• Physicochemical properties of antibacterial compounds: implications for drug discovery.

  2008cited by this paper
• Marine Actinomycetes: A New Source of Compounds against the Human Malaria Parasite

  2008cited by this paper
• A New Antimalarial Polyether from a Marine Streptomyces sp. H668.

  2008cited by this paper
• Combination antifungal therapy: what can and should we expect?

  2007cited by this paper
• Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium.

  2007cited by this paper
• Current understanding of the molecular basis of chloroquine-resistance in Plasmodium falciparum.

  2006cited by this paper
• Capisterones A and B, which enhance fluconazole activity in Saccharomyces cerevisiae, from the marine green alga Penicillus capitatus.

  2006cited by this paper
• Antiplasmodial metabolites isolated from the marine octocoral Muricea austera.

  2006cited by this paper
• Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice.

  2005cited by this paper
• Antibacterial resistance worldwide: causes, challenges and responses

  2004cited by this paper
• Antifungal resistance: the clinical front.

  2004cited by this paper
• Use of newer antifungal therapies in clinical practice: what do the data tell us?

  2004cited by this paper
• Time-related differences in the physical property profiles of oral drugs.

  2004cited by this paper
• Reversal of fluconazole resistance in multidrug efflux-resistant fungi by the Dysidea arenaria sponge sterol 9alpha,11alpha-epoxycholest-7-ene-3beta,5alpha,6alpha,19-tetrol 6-acetate.

  2003cited by this paper
• Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum.

  2003cited by this paper
• Molecular properties that influence the oral bioavailability of drug candidates.

  2002cited by this paper
• Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.

  2002cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism.

  1998cited by this paper

• Pan-cancer analysis of CDC7 in human tumors: Integrative multi-omics insights and discovery of novel marine-based inhibitors through machine learning and computational approaches

  2025cites this paper
• Diterpenoids of Marine Organisms: Isolation, Structures, and Bioactivities

  2025cites this paper
• Molecular docking and pharmacokinetics of Roweothuria polii compounds with in vivo anti-Eimeria papillata activity

  2025cites this paper
• Identifying a Marine-Derived Small-Molecule Nucleoprotein Inhibitor Against Influenza A Virus

  2025cites this paper
• Polysaccharides and flavonoids from seaweeds: A natural arsenal against drug-resistant malaria

  2025cites this paper
• Antimicrobial activity of some bacteria isolated from marine sponge in Neom region, Saudi Arabia

  2025cites this paper
• Discovery of New Everninomicin Analogs from a Marine-Derived Micromonospora sp. by Metabolomics and Genomics Approaches

  2025cites this paper
• Mangrove derived metabolites as potential antibacterial leads: An integrated in silico study

  2025cites this paper
• One Strain Many Compounds Approach for Anti-Trypanosoma cruzi Compounds: Empowering the Marine Bacterium Metabacillus indicus

  2025cites this paper
• Marine Natural Products in Inflammation‐Related Diseases: Opportunities and Challenges

  2025cites this paper
• TRAF6 Inhibitors from Marine Compound Library: Pharmacophore, Virtual Screening, Fragment Replacement, ADMET, and Molecular Dynamics

  2024cites this paper
• Pillar[5]arene/albumin biosupramolecular systems for simultaneous native protein preservation and encapsulation of a water-soluble substrate.

  2024cites this paper
• Exosome-decorated bio-heterojunctions reduce heat and ROS transfer distance for boosted antibacterial and tumor therapy.

  2024cites this paper
• Estimation of antiparasitic activity of fungal extracts towards Leishmania donovani in murine model

  2024cites this paper
• Cytotoxic and proliferation-inhibitory activity of natural and synthetic fungal tropolone sesquiterpenoids in various cell lines

  2024cites this paper
• Design of Marine Cyclodepsipeptide Analogues Targeting Candida albicans Efflux Pump CaCdr1p

  2024cites this paper
• Prospects of marine-derived compounds as potential therapeutic agents for glioma

  2024cites this paper
• In silico and In vitro Assessment of Dimeric Flavonoids (Brachydins) on Rhipicephalus microplus Glutathione S-transferase.

  2024cites this paper
• Studies on bioactivities of Manuka and regional varieties of honey for their potential use as natural antibiotic agents for infection control related to wound healing and in pharmaceutical formulations

  2024cites this paper
• Antifungal and Antibacterial Activities of Isolated Marine Compounds

  2023cites this paper
• Exploring Marine Sponge Metabolites as Promising Leads for Alzheimer’s Disease: Virtual Screening, ADMET Analysis, and Molecular Dynamics Simulations

  2023cites this paper
• Characterisation of physicochemical parameters and antibacterial properties of New Caledonian honeys

  2023cites this paper
• Marine Invertebrate Antimicrobial Peptides and Their Potential as Novel Peptide Antibiotics

  2023cites this paper
• Fish Skin Mucus Extracts: An Underexplored Source of Antimicrobial Agents

  2023cites this paper
• A One Health approach to overcoming fungal disease and antifungal resistance.

  2023cites this paper
• First continuous marine sponge cell line established

  2023cites this paper
• Design, synthesis, antiviral and fungicidal activities of novel polycarpine simplified analogues.

  2023cites this paper
• Unveiling the Efficacy of Sesquiterpenes from Marine Sponge Dactylospongia elegans in Inhibiting Dihydrofolate Reductase Using Docking and Molecular Dynamic Studies

  2023cites this paper
• Steroid and triterpenoid compounds with antiparasitic properties.

  2023cites this paper
• A Survey on the Synthesis of Variolins, Meridianins, and Meriolins—Naturally Occurring Marine (aza)Indole Alkaloids and Their Semisynthetic Derivatives

  2023cites this paper
• Total Synthesis of Suberitines A-D Featuring Tunable Biomimetic Late-Stage Oxidative Dearomatization and Acetalization.

  2022cites this paper
• Anti-leishmanial effects of resveratrol and resveratrol nanoemulsion on Leishmania major

  2022cites this paper
• Recent Advances in Cell Membrane-Coated Technology for Drug Discovery from Natural Products

  2022cites this paper
• Cladiella Octocorals: Enormous Sources of Secondary Metabolites with Diverse Structural and Biological Properties

  2022cites this paper
• Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy

  2022cites this paper
• Metabolic Profiling of Streptomyces sp. Strain ess_amH1 Isolated from Apis mellifera yemintica’s Gut Microbiome, and Its Anticancer Activity against Breast Cancer (MCF7) and Hepatocarcinoma (HepG2) Cell Lines, as Well as Antimicrobial Activity

  2022cites this paper
• Antimicrobial therapeutics isolated from algal source: retrospect and prospect

  2022cites this paper
• New Halogenated Compounds from Halimeda macroloba Seaweed with Potential Inhibitory Activity against Malaria

  2022cites this paper
• In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective

  2022cites this paper
• Bioactive natural products in COVID-19 therapy

  2022cites this paper
• Detection of Staphylococcus aureus from contact surfaces of public buses in Bangkok and metropolitan area, Thailand

  2022cites this paper
• Marine Compounds with Anti-Candida sp. Activity: A Promised “Land” for New Antifungals

  2022cites this paper
• The Inhibition of RNA Viruses by Amaryllidaceae Alkaloids: Opportunities for the Development of Broad-Spectrum Anti-Coronavirus Drugs.

  2022cites this paper
• Spirolactone-type and enmein-type derivatives as potential anti-cancer agents derived from oridonin.

  2022cites this paper
• Marine Natural Products — a Vital Source of Novel Biotherapeutics

  2022cites this paper
• ACTINOMYCETES AS A SOURCE OF POTENTIAL ANTIMICROBIAL AND ANTIBIOFILM AGENTS

  2022influential citation
• Metabolic profiling and biological potential of the marine sponge associated Nocardiopsis sp. UR67 along with docking studies

  2022cites this paper
• The Immune System of Marine Organisms as Source for Drugs against Infectious Diseases

  2022cites this paper
• Natural products as Zika antivirals

  2022cites this paper
• Multifaceted role of natural sources for COVID-19 pandemic as marine drugs

  2022cites this paper
• New glucose-6-phosphate dehydrogenase inhibitor from the Red Sea sponge Echinoclathria sp

  2021cites this paper
• The effect of natural antimicrobials against Campylobacter spp. and its similarities to Salmonella spp, Listeria spp., Escherichia coli, Vibrio spp., Clostridium spp. and Staphylococcus spp

  2021cites this paper
• Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles

  2021cites this paper
• Caspase Cascade Activation During Apoptotic Cell Death of Human Lung Carcinoma Cells A549 Induced by Marine Sponge Callyspongia aerizusa

  2021cites this paper
• The potency of actinomycetes extracts isolated from Pramuka Island, Jakarta, Indonesia as antimicrobial agents

  2021cites this paper
• Antibacterial potential of selected phytomolecules: An experimental study

  2021cites this paper
• Microbial Screening of Marine Natural Product Inhibitors for the 6′-Aminoglycoside Acetyltransferase 2″-Aminoglycoside Phosphotransferase [AAC(6′)-APH(2″)] Bifunctional Enzyme by Ultra-High Performance Liquid Chromatography–Mass Spectrometry (UHPLC-MS)

  2021cites this paper
• Antibacterial polyene-polyol macrolides and cyclic peptides from the marine-derived Streptomyces sp. MS110128

  2021cites this paper
• Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study

  2021cites this paper
• Therapeutic Potential of Neoechinulins and Their Derivatives: An Overview of the Molecular Mechanisms Behind Pharmacological Activities

  2021cites this paper
• Chemical compositions and experimental and computational modeling activity of sea cucumber Holothuria parva ethanolic extract against herpes simplex virus type 1.

  2021cites this paper
• The Anti-Viral Applications of Marine Resources for COVID-19 Treatment: An Overview

  2021cites this paper
• Material-herbology: An effective and safe strategy to eradicate lethal viral-bacterial pneumonia

  2021cites this paper
• Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds

  2021cites this paper
• Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products

  2021cites this paper
• Photeroids A and B, unique phenol-sesquiterpene meroterpenoids from the deep-sea-derived fungus Phomopsis tersa.

  2020cites this paper
• CRISPR/Cas12a-Mediated Gene Editing in Geodia barretti Sponge Cell Culture

  2020cites this paper
• Targeting bacterial antioxidant systems for antibiotics development.

  2020cites this paper
• Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation

  2020cites this paper
• Metabolomics and Marine Biotechnology: Coupling Metabolite Profiling and Organism Biology for the Discovery of New Compounds

  2020cites this paper
• Colombian Contributions Fighting Leishmaniasis: A Systematic Review on Antileishmanials Combined with Chemoinformatics Analysis

  2020cites this paper
• Antibiotics from Marine Bacteria

  2020cites this paper
• Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease

  2020cites this paper
• Study of the Component Structure of the Metabolites of Bacteria Nocardiopsis umidischolae in the Search for Eco-Friendly Plant Protection Agents

  2020cites this paper
• The genus Micromonospora as a model microorganism for bioactive natural product discovery

  2020cites this paper
• Natural Products Repertoire of the Red Sea

  2020cites this paper
• A reusable AuNPS with increased stability applied for fast screening of trace heavy metals in edible and medicinal marine products.

  2020cites this paper
• Hepatitis C Virus NS3 Protease and Helicase Inhibitors from Red Sea Sponge (Amphimedon) Species in Green Synthesized Silver Nanoparticles Assisted by in Silico Modeling and Metabolic Profiling

  2020cites this paper
• Targeting Antimicrobial Drug Resistance with Marine Natural Products.

  2020cites this paper
• New Cytotoxic Natural Products from the Red Sea Sponge Stylissa carteri

  2020cites this paper
• Oxidative Stress-Generating Antimicrobials, a Novel Strategy to Overcome Antibacterial Resistance

  2020cites this paper
• Antibiotics Development and the Potentials of Marine-Derived Compounds to Stem the Tide of Multidrug-Resistant Pathogenic Bacteria, Fungi, and Protozoa

  2020cites this paper
• New bioactive metabolites from the elicited marine sponge-derived bacterium Actinokineospora spheciospongiae sp. nov.

  2019cites this paper
• Marine Microbial Bioactive Compounds: New Way to Treat Resistance of Neglected Tropical Diseases

  2019cites this paper
• Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens.

  2019cites this paper
• Characterization of the Noncanonical Regulatory and Transporter Genes in Atratumycin Biosynthesis and Production in a Heterologous Host

  2019cites this paper
• Distribution and Bioprospecting Potential of Actinobacteria from Indian Mangrove Ecosystems

  2019cites this paper
• Chemical and Bioactive Marine Natural Products of Coral-Derived Microorganisms (2015‒2017).

  2019cites this paper
• Natural Product Synthesis by Fungi: Recent Trends and Future Prospects

  2019cites this paper
• Microbiota of the alien species Paraleucilla magna (Porifera, Calcarea) from the Southwestern Atlantic, and a comparison with that of other calcareous sponges

  2019cites this paper
• Potential of marine natural products against drug-resistant bacterial infections.

  2019cites this paper
• Marine Macrolides with Antibacterial and/or Antifungal Activity

  2019cites this paper
• Genome- and MS-based mining of antibacterial chlorinated chromones and xanthones from the phytopathogenic fungus Bipolaris sorokiniana strain 11134

  2019cites this paper
• Have marine natural product drug discovery efforts been productive and how can we improve their efficiency?

  2019cites this paper
• Recent Updates on Corals from Nephtheidae

  2019cites this paper
• Total synthesis of spiromastilactone A.

  2019cites this paper
• Marine natural products as potential anti-tubercular agents.

  2019cites this paper
• Marine natural products.

  2019cites this paper
• A New Bioactive Compound From the Marine Sponge-Derived Streptomyces sp. SBT348 Inhibits Staphylococcal Growth and Biofilm Formation

  2018cites this paper
• Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?

  2018cites this paper